GENMAB A/S -SP ADR (GMAB:NASDAQ)
$33.29 -0.81 (-2.3754%)
Analysed GENMAB A/S -SP ADR (GMAB:NASDAQ) News Sources
Genmab shares jump 8% after upbeat results prompt 2026 outlook raise
06-08-2026
yahoo.com
Genmab A/S Q2 Earnings Call Highlights
06-08-2026
marketbeat.com
Genmab AS (GMAB) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Strategic ...
06-08-2026
yahoo.com
Genmab Stock Rises 4.4% as Drug Royalties Lift Outlook
07-08-2026
yahoo.com
Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab?
13-08-2026
yahoo.com
Here Are Wednesday’s Top Wall Street Analyst Research Calls: The Gap, Genmab, Hilton Worldwide, Intuitive Surgical, Marriott International, Merck, Novo Nordisk, Okta, and More
12-08-2026
247wallst.com
Genmab (GMAB) Q2 2026 Earnings Call Transcript
07-08-2026
fool.com
Capital Increase in Genmab as a Result of Employee Warrant Exercise
11-08-2026
yahoo.com
Genmab to Participate in Upcoming Investor Conferences
25-08-2026
yahoo.com
Could Genmab (GMAB) Stock Win as Royalty Growth Fuels a New Earnings Cycle?
26-08-2026
yahoo.com
What is the current price of GENMAB A/S -SP ADR (GMAB:NASDAQ)?
The current price of GENMAB A/S -SP ADR (GMAB:NASDAQ) is $33.29.
GENMAB A/S -SP ADR (GMAB:NASDAQ) absolute price change since previous trading day?
The absolute price change of GENMAB A/S -SP ADR (GMAB:NASDAQ) since the previous trading day is $-0.81.
GENMAB A/S -SP ADR (GMAB:NASDAQ) percentage price change since previous trading day?
The percentage price change of GENMAB A/S -SP ADR (GMAB:NASDAQ) since the previous trading day is -2.3754%.
What is the most recent average sentiment score for GENMAB A/S -SP ADR (GMAB:NASDAQ)?
The most recent average sentiment score for GENMAB A/S -SP ADR (GMAB:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for GENMAB A/S -SP ADR (GMAB:NASDAQ)?
The most recent sentiment for GENMAB A/S -SP ADR (GMAB:NASDAQ) is .
SEC-8K** Filing Available For GENMAB A/S -SP ADR (GMAB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.